Key result
Advanced proteomic technologies provide improved tools for analyzing protein S-nitrosylation across various pathophysiological settings.
This review highlights advances in proteomic technologies for evaluating protein S-nitrosylation in various pathophysiological settings.
May inform SNO-targeted diagnostics in CV disease; leaves open clinical adoption pending prospective validation of MS methods.
Many of nitric oxide (NO) actions are mediated through the coupling of a nitroso moiety to a reactive cysteine leading to the formation of a S-nitrosothiol (SNO), a process known as S-nitrosylation or S-nitrosation. In many cases this reversible post-translational modification is accompanied by altered protein function and aberrant S-nitrosylation of proteins, caused by altered production of NO and/or impaired SNO homeostasis, has been repeatedly reported in a variety of pathophysiological settings. A growing number of studies are directed to the identification and characterization of those proteins that undergo S-nitrosylation and the analysis of S-nitrosoproteomes under pathological conditions is beginning to be reported. The study of these S-nitrosoproteomes has been fueled by advances in proteomic technologies that are providing researchers with improved tools for exploring this post-translational modification. Here we review novel refinements and improvements to these methods, and some recent studies of the S-nitrosoproteome in disease.
No takes yet. Share an insight, caveat, or question.
López‐Sánchez et al. (2013) reported a review. Proteomic approaches was evaluated. Advances in proteomic technologies are providing improved tools for exploring protein S-nitrosylation and analyzing S-nitrosoproteomes in various pathophysiological settings.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: